New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies (R01 - Clinical Trial Optional)

The National Institutes of Health (NIH) is seeking applications for research to overcome barriers that limit progress toward more effective open- and closed-loop diabetes control systems. This may include research that addresses innovation of sensing relevant analytes/physiologic signals, novel formulation and delivery of hormones, artificial intelligence (AI)/machine learning (ML)-driven tools/algorithms, and digital twin modeling to augment decision support and automated control systems. The goal is to improve glycemic control, reduce burden of care, and enhance quality of life of people with type 1 diabetes (T1D). • The research should focus on the development of new technologies that incorporate AI/ML tools and strategies to improve diabetes control systems. • The application should include a clear plan for the development and testing of the proposed technology. • The applicant should have a strong track record of research in the field of diabetes and technology development. • The application should include a detailed budget and timeline for the proposed research. • The applicant should be prepared to collaborate with other researchers and stakeholders in the field of diabetes research.